Article
Ex vivo validation of osteogenic efficacy in a bioceramic dual drug-delivery system
2025-08-26
Abstract excerpt
<title>Abstract</title> <p> Alendronate (ALN) is widely employed against skeletal disorders, but its low oral bioavailability and prolonged skeletal retention necessitate high systemic doses that carry significant risk. The research team previously developed a novel bioceramic drug-delivery system (DDS) that sequentially releases gentamicin during the first two weeks post-implantation (with reported therapeutic...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- eab4f664-6dd1-5eec-ac77-549388244bf4
- DOI
- 10.21203/rs.3.rs-7274523/v1
